Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.20p
   
  • Change Today:
      0.050p
  • 52 Week High: 13.55
  • 52 Week Low: 2.40
  • Currency: UK Pounds
  • Shares Issued: 697.20m
  • Volume: 1,921,228
  • Market Cap: £22.31m

Director dealings: Poolbeg Pharma co-founder raise stake

By Iain Gilbert

Date: Wednesday 25 Jun 2025

LONDON (ShareCast) - (Sharecast News) - Poolbeg Pharma revealed on Wednesday that executive chair Cathal Friel had acquired 4.0m new ordinary shares in the AIM-listed biopharmaceuticals company.
Friel, who co-founded Poolbeg, purchased the shares on Friday at an average price of 2.5p per share, for a total value of £100,000.

Following the transaction, Friel holds a total of 41.21m ordinary Poolbeg shares, representing approximately 5.91% of the company's issued share capital.

As of 1545 BST, Poolbeg shares were up 6.55% at 3.09p.





Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Record (REC)
Director name: Witte,Jan
Amount purchased: 340,171 @ 54.41p
Value: £185,087.04

Record (REC)
Director name: Heading,Richard
Amount purchased: 340,171 @ 54.41p
Value: £185,087.04

Poolbeg Pharma (POLB)
Director name: Friel,Cathal
Amount purchased: 4,000,000 @ 2.50p
Value: £100,000.00

Record (REC)
Director name: Ayles,Kevin
Amount purchased: 48,462 @ 54.41p
Value: £26,368.17

Intercede Group (IGP)
Director name: Leest ,Klaas van der
Amount purchased: 12,450 @ 178.16p
Value: £22,180.92

Experian (EXPN)
Director name: DeRose,Kathleen
Amount purchased: 480 @ $52.29
Value: $20,696.01

Molten Ventures (GROW)
Director name: Zimmermann,Andrew
Amount purchased: 5,871 @ 288.02p
Value: £16,909.65

Experian (EXPN)
Director name: DeRose,Kathleen
Amount purchased: 320 @ $51.80
Value: $13,668.67

Intercede Group (IGP)
Director name: Leest ,Klaas van der
Amount purchased: 5,000 @ 178.80p
Value: £8,940.00

Intercede Group (IGP)
Director name: Leest ,Klaas van der
Amount purchased: 5,000 @ 176.00p
Value: £8,800.00

Molten Ventures (GROW)
Director name: Zimmermann,Andrew
Amount purchased: 1,047 @ 285.04p
Value: £2,984.37

Ultimate Products (ULTP)
Director name: Dent,Chris
Amount purchased: 1,992 @ 50.18p
Value: £999.54

Cranswick (CWK)
Director name: Aldersley,Christopher
Amount purchased: 3 @ 5,327.00p
Value: £159.81

Spirent Communications (SPT)
Director name: Bell,Paula
Amount purchased: 65 @ 192.40p
Value: £125.06



Top Director Sells

Costain Group (COST)
Director name: Vaughan,Alex
Amount sold: 241,639 @ 144.00p
Value: £347,960.17

Bytes Technology Group (BYIT)
Director name: Mudd,Sam
Amount sold: 65,264 @ 499.94p
Value: £326,278.89

Costain Group (COST)
Director name: Vaughan,Alex
Amount sold: 214,285 @ 142.00p
Value: £304,284.69

Costain Group (COST)
Director name: Willis,Helen
Amount sold: 100,082 @ 142.00p
Value: £142,116.44

Picton Property Income Ltd (PCTN)
Director name: Morris ,Michael
Amount sold: 142,225 @ 80.05p
Value: £113,851.11

Bytes Technology Group (BYIT)
Director name: Mudd,Sam
Amount sold: 20,548 @ 499.94p
Value: £102,727.06

Gaming Realms (GMR)
Director name: Robert Green,Geoffrey
Amount sold: 200,000 @ 51.36p
Value: £102,720.00

Costain Group (COST)
Director name: Willis,Helen
Amount sold: 56,429 @ 144.00p
Value: £81,257.76

Picton Property Income Ltd (PCTN)
Director name: Morris ,Michael
Amount sold: 92,909 @ 80.05p
Value: £74,373.65

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 3.20p
Change Today 0.050p
% Change 1.59 %
52 Week High 13.55
52 Week Low 2.40
Volume 1,921,228
Shares Issued 697.20m
Market Cap £22.31m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.6% below the market average53.6% below the market average53.6% below the market average53.6% below the market average53.6% below the market average
13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average
Price Trend
87.64% below the market average87.64% below the market average87.64% below the market average87.64% below the market average87.64% below the market average
73.91% below the sector average73.91% below the sector average73.91% below the sector average73.91% below the sector average73.91% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 11-Jul-2025

Time Volume / Share Price
17:05 750,000 @ 3.20p
16:36 29,000 @ 3.18p
16:35 32,000 @ 3.20p
16:35 32,000 @ 3.20p
16:23 24 @ 3.20p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page